← Open Payments lookup

PHOMMALONE NGUYEN: Open Payments

NPI 1851756589 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,636 in 25 payments from 18 companies in 2025. Trend: 2023 $1,919 · 2024 $2,731 · 2025 $2,636

Food & beverage: $2,636
CompanyPaymentsAmount
Gilead Sciences, Inc.3$375
GENZYME CORPORATION3$358
ABBVIE INC.2$215
GlaxoSmithKline, LLC.2$157
Averitas Pharma Inc.2$150
Ipsen Biopharmaceuticals, Inc1$133
AstraZeneca Pharmaceuticals LP1$122
Phathom Pharmaceuticals, Inc.1$114
Medtronic, Inc.1$113
ViiV Healthcare Company1$113

Products named: QUTENZA, Yeztugo, IQIRVO, MAVYRET, TEZSPIRE, KEVZARA, VOQUEZNA, INTELLIS ADAPTIVESTIM.

Industry payments across TX — which companies pay providers there.